Sherry Korczynski Aquestive Therapeutics, Inc. (AQST) insider trading activity

AQST Quotes by TradingView

Sherry Korczynski is Chief Commercial Officer of Aquestive Therapeutics, Inc.. Currently has a direct ownership of 181,858 shares of AQST, which is worth approximately $936,568. The most recent transaction as insider was on Aug 14, 2025, when has been sold 25,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 182K
13.97% 3M change
627.43% 12M change
Total Value Held $936,568

Sherry Korczynski Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 14 2025
BUY
Grant, award, or other acquisition
-
25,000 Added 12.09%
181,858 Common Stock
Jun 09 2025
SELL
Payment of exercise price or tax liability
$9,607 $3.54 p/Share
2,714 Reduced 1.7%
156,858 Common Stock
Mar 07 2025
SELL
Payment of exercise price or tax liability
$14,384 $2.65 p/Share
5,428 Reduced 3.29%
159,572 Common Stock
Mar 07 2025
BUY
Grant, award, or other acquisition
-
90,000 Added 35.29%
165,000 Common Stock
Jun 07 2024
BUY
Grant, award, or other acquisition
-
25,000 Added 50.0%
25,000 Common Stock
SK

Sherry Korczynski

Chief Commercial Officer
Warren, NJ

Track Institutional and Insider Activities on AQST

Follow Aquestive Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AQST shares.

Notify only if

Insider Trading

Get notified when an Aquestive Therapeutics, Inc. insider buys or sells AQST shares.

Notify only if

News

Receive news related to Aquestive Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AQST